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Abstract
Background: Tumor necrosis factor (TNFA) is the canonical member of the TNF superfamily, which plays a major
role in both inflammation and apoptosis. To evaluate the role of TNFs in otitis media (OM), the most common
disease of childhood, we evaluated middle ear (ME) expression of genes encoding the TNF and TNF receptor
superfamilies during bacterial OM in the mouse, characterized OM in TNFA-deficient mice, and assessed apoptosis
during OM in normal versus TNF-deficient MEs.
Results: TNFs and TNF receptors were broadly regulated during OM, with TNFA showing the highest level of up-
regulation. TNF deficient mice exhibited mucosal hyperplasia even in the absence of infection and exuberant
growth of the mucosa during OM, including the formation of mucosal polyps. Mucosal recovery during OM was
also delayed, in parallel with a delay in mucosal apoptosis and reduced caspase gene expression.
Conclusions: The TNF and TNF receptor superfamilies mediate both inflammation and apoptosis during OM. TNF
appears to be critical for the maintenance of mucosal architecture in both the normal and infected ME, since
excessive accumulation of mucosal tissue is seen in TNFA-/- MEs both before and after bacterial inoculation of the
ME. TNFA is also required for appropriate regulation of caspase genes.
Background
Tumor necrosis factor (TNFA, TNFSF2), formally
known as TNFa, is a pleiotropic cytokine widely
involved in apoptosis as well as cell proliferation,
immune and inflammatory reactions. It is produced by
activated macrophages and mast cells, and also by
epithelial and stromal cells. TNFA is the founding mem-
ber of the TNF superfamily, now composed of more
than 20 members. Through interaction with their large
family of cognate TNF receptors (TNFRs), TNFs can
activate transcription factors such as NF-B and c-Jun,
which modulate expression of genes related to apoptosis
and various other cellular responses, or via TNFR death
domains which can directly stimulate cell death [1-5].
Together with interleukin-1b, TNFA is considered one
of the primary cytokines of middle ear (ME) inflamma-
tion [6]. In the early stage of inflammation, TNFA is
produced by the ME mucosa and in the late stage also
by accumulating inflammatory cells. TNFA is induced
by bacterial pathogens, both Gram-positive and Gram-
negative and it participates in viral otitis media (OM)
[7-9]. Elevated levels of TNFA in the ME fluids of
patients with OM are very common [10]. In rat and
mouse models of acute OM, the expression of TNFA
transcripts in the ME mucosa increased substantially
within six hours after challenge with nontypeable Hae-
mophilus influenzae (NTHi) [11,12]. However, the
expression of most other TNF family members and of
TNF receptors has not been extensively documented
in OM.
TNFA has been demonstrated to up-regulate mucin
genes in the ME epithelium [13] and thus probably
plays an essential role in the pathogenesis of mucoid
OM. Transtympanic injection of TNFA into normal
MEs causes OM [14], which can be attenuated by simul-
taneous administration of TNF soluble receptor type I
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(TNFsolRI) [15]. Anti-TNFA antibodies have been sug-
gested as a treatment option for OM (reviewed by Smir-
nova et al. [6]). However, we have previously shown that
mice lacking TNFA show a failure to clear bacteria from
the ME, accompanied by abnormalities in phagocytosis
and intracellular killing by macrophages, and delayed
OM resolution [12]. All these findings indicate a broad
involvement of TNFA in the inflammatory reaction dur-
ing OM.
TNFA also plays a major role in apoptosis. Given the
delayed resolution of OM observed in TNFA-deficient
mice [12], this raises the question of whether TNFA’s
apoptotic function might contribute to remodeling of
the ME mucosa as well as its return to normal structure
during recovery from OM. Supporting this concept, dys-
regulation of TNFA signaling has been reported to be
involved in the pathogenesis of nasal polyposis [16] as
well as colon polyps [17], reflecting the apoptotic effects
of TNFA and alterations of the epithelial architecture
due to the accumulation of excess mucosal cells in its
absence. Several other members of the TNF and TNFR
families are also involved in apoptosis [4,5]. Very few
studies have addressed the role of apoptosis, including
TNF-mediated cell death, in OM, although it has been
demonstrated that mice lacking TNFR6, also known as
Fas, show delayed recovery from bacterial OM [18].
To explore the role of the TNF superfamily in regulat-
ing apoptosis during OM, we used gene arrays to evalu-
ate the expression of genes encoding all members of the
TNF and TNFR superfamilies during NTHi-induced
OM in the mouse. In addition, we induced bacterial
OM [19] in TNFA-/- and wild-type (WT) mice. We
determined the effects of TNFA deletion on mucosal
hyperplasia and remodeling as well as upon the course
of apoptosis within the ME mucosa during the course of
a ME infection.
Results
Expression of TNF and TNFR genes
Of the 23 known TNF superfamily genes, 7 were signifi-
cantly regulated during OM, as illustrated in Figure 1A,
and in the Additional File 1, Table S1. The Tnfa gene
itself was strongly and significantly up-regulated from
25-fold to more than 100-fold over the period from
3 hours to 3 days after NTHi inoculation, and 2-fold at
day 5, when compared to uninoculated (0 hr) controls.
Tnf14 was up-regulated up to 25-fold, the Tnf9 gene over
5-fold, and Tnf13b up to 3-fold, over a similar time
course. Tnf11 was more briefly up-regulated more than
6-fold from 3-24 hours, while Tnf10 was up-regulated
more than 2-fold at 6 hours and, in contrast to the other
genes, remained so throughout the experiment. Only one
gene, Tnf4, was down-regulated with expression
decreased to ~30% of that seen in the control ME 1 and
2 days after NTHi inoculation. Thus, all three TNF family
genes with known pro-apoptotic functions (Tnfa, Tnf9
and Tnf10) and one TNF gene with anti-apoptotic func-
tion (Tnf11) were up-regulated during OM.
Eleven members of the TNFR superfamily were regulated
during OM, as illustrated in Figures 1B and 1C, and in
the Additional File 1, Table S1. While the Tnfr1a and
Tnfr18 genes were significantly up-regulated from
6 hours to 2 days, the Tnfr1b, Tnfr9, and Tnfr12a genes
were much more strongly up-regulated from 3 hours to
3 days. While increasing with a similar pattern, Tnfr5 and
Tnfr11b mRNA appeared to remain elevated until 7 days.
Tnfr22 and Tnfr23 mRNAs were not up-regulated until
1 day after inoculation, and then decreased rapidly.
Tnfr13b and Tnfr19 were also up-regulated relatively late,
but remained elevated even at 5 and 7 days after ME
infection. Down-regulation of TNFR genes was rare, with
only Tnfr1a and Tnfr23 showing significantly reduced
expression at 7 days. Thus, of the TNF receptor genes
with known pro-apoptotic function, Tnfr1a, Tnfr1b, and
Tnfr9 were up-regulated, as was the anti-apoptotic recep-
tor gene Tnfr11b.
Middle Ear Histology
As we have described previously [20-22] in WT mice
ME mucosal hyperplasia was observed starting on day 1
and peaked on day 2 after NTHi inoculation. On day 3
the ME mucosa remained significantly hyperplastic, but
by day 5 it had recovered to near normal thickness
(Figure 2). When the mucosa was divided into its
epithelial and stromal compartments however, as shown
in Figure 3A and 3B, recovery of epithelial thickness
was not complete until day 10, while the stroma had
recovered by day 5. The proportion of the ME mucosa
occupied by infiltrating leukocytes was highest on day 1,
and decreased regularly until few cells were observed on
day 5 and virtually none on day 7.
A significant difference between TNFA-/- mice and
WT mice was observed even in untreated animals: both
epithelial and stromal compartments of the ME mucosa
were significantly hyperplastic in the absence of TNFA
(Figures 2, 3A,B). Thereafter, the mucosa of both WT
and TNFA-/- increased when compared to uninoculated
animals (p < .05), such that significant differences
between WT and TNFA-/- mice in the thickness of the
ME mucosa epithelium or stroma were not observed
until day 5 after infection. As noted above, the epithe-
lium of the WT mice began to return to its normal
thickness on day 5 and was normal by day 10, while the
epithelium of the TNF knockout (KO) mice remained
hyperplastic. The ME mucosal stroma of the TNFA-/-
animals showed no decrease in thickness on day 5, but
did recover somewhat on day 7. However, it remained
significantly thicker than the WT even on day 10.
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Figure 1 Relative expression of TNF and TNF receptor superfamily genes during acute OM in the mouse. A. mRNA encoding genes of
the 23-member TNF superfamily in the ME mucosa was evaluated on Affymetrix whole-genome gene arrays. Data are expressed as fold
induction over untreated ME mucosa (0 h). Only significantly regulated genes are shown. Each data point represents gene arrays obtained from
2 independent sets of 20 C57BL/6J mice each. B,C. Relative expression of TNF receptor superfamily genes during acute OM in the mouse.
Significantly regulated members of this large (29 member) gene family are represented in the two panels of this figure. = P < .05; ** = P < .01;
*** = P < .001.
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While the thickness of the TNFA-/- ME mucosa in
most areas was similar to that in WTs from 1-5 days
after inoculation, localized increases in thickness were
observed in TNFA-/- mice. Challenge with NTHi
resulted in the formation of mucosal polyps in a high
percentage of MEs of TNFA-/- mice from 1-7 days after
infection. In WT mice, polyp formation was observed in
only one ME, on day 1 post infection. Unchallenged ani-
mals, either WT or TNFA-deficient, did not exhibit
mucosal polyps (Figure 4A and 4B).
Lack of TNF also influenced infiltration of the ME by
leukocytes. In TNFA-/- animals, more cells entered the
ME. Moreover, apparently viable leukocytes were pre-
sent in the ME for a longer period (Figure 5A). This dif-
ference reached significance by day 5, and remained so
on day 10. In addition, the character of the cells was
also different (Figure 5B). Almost all of the cells
observed in the WT ME on day one were neutrophils,
as we have noted previously [12]. In contrast, significant
numbers of macrophages were observed in the TNFA-/-
MEs, at this time. Moreover, by day 5 when macro-
phages dominated the few cells remaining in the WT
ME, TNFA-/- MEs contained a high proportion of
neutrophils.
Apoptosis
The time course of apoptosis in the ME mucosa of WT
mice, represented by the percentage of TUNEL-positive
cells, is illustrated in Figure 6. Apoptotic cells were
observed in the mucosal epithelium and stroma (Figure
6A) as well as among infiltrating leukocytes. As
expected, counts of apoptotic cells (Figure 6B) revealed
a low level of baseline level of apoptosis even in the
uninfected WT ME. This was maintained during OM,
but showed a single significant peak on day 5 after
infection, at the time when mucosal thickening was
returning to baseline. In the absence of TNF, increased
apoptosis was delayed until 7 days post infection, and
remained significantly higher than observed in WTs at
10 days.
To further address the mechanism of changes in
apoptosis, we evaluated, using qPCR (Figure 7), the
expression of the primary effector caspase, caspase 3,
and caspase 4 which serves both inflammatory and
apoptotic roles [23,24]. Expression of both caspases
was low in uninfected WT MEs. Following ME infec-
tion, no change in caspase 3 mRNA was noted until
day 5, when expression was up-regulated before
returning to its original level by day 10. Caspase 4
Figure 2 Middle ear response to NTHi challenge in WT vs. TNF-deficient mice. H&E stained sections from untreated MEs and MEs at 1, 2, 3,
5, 7 and 10 days after NTHi inoculation. The examples illustrated are representative of the typical response seen in MEs for that time and
genotype. However, cellular infiltrates were irregularly distributed so that a match to quantitative data achieved across the entire ME was not
always possible. Ep = ME mucosal epithelium. Str = ME mucosal stroma. Original magnification 100×.
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showed a strong peak 6 hours after NTHi inoculation
in WT mice, followed by a decline and then a second,
albeit lower peak at day 5. In TNFA-/- mice, both cas-
pases 3 and 4 were expressed at moderate levels prior
to NTHi inoculation. However, after inoculation their
expression rapidly decreased to very low levels, and
remained so through day 10.
Discussion
The regulation of multiple TNF and TNFR superfamily
genes during OM indicates the importance of these
gene families to the disease process and also presumably
reflects the pleiotropic nature of TNF/TNFR function.
While changes in TNF/TNFR signalling could be
mediated by the observed regulation of TNF/TNFR
genes, signalling is also likely to be modulated indepen-
dent of gene regulation through post-translational modi-
fication. It is known that post-translational changes in
mRNA splicing or in the effector proteins can strongly
influence TNF/TNFR interactions [4,5], and we
acknowledge that our gene array data do not address
this point. However, conclusions can be drawn based on
the particular TNFs and TNFRs whose genes did exhibit
regulation during OM.
Of the TNF superfamily members encoded by genes
that were significantly regulated, TNFA and TNF10
(TRAIL) activate TNF receptors (TNFR1a, TNFR1b,
TNFR10) that contain death domains [5,25,26], and thus
are likely to induce apoptosis. Of the regulated TNFs
that activate receptors without a death domain, TNF9
can enhance apoptosis indirectly by inducing prolonged
expression of TNF [27,28]; TNF11 and TNF14 can be
anti-apoptotic [29-31], while others appear to have only
non-apoptotic functions (TNF4; T-cell recruitment, pro-
liferation and cytokine production [32]; TNF13B, B-cell
activation [33]).
Not all of the genes encoding receptors for the above
TNFs were themselves regulated, and conversely some
receptor genes were regulated in the absence of gene
Figure 3 Thickness of the ME mucosa of WT vs. TNFA-/- mice
during NTHi-induced OM. A. Thickness of the ME mucosal
epithelium in WT (stippled bars) and TNFA-/- (striped bars) mice. B.
Thickness of the mucosal stroma. Bars represent means, while lines
represent 1 SD. * = p ≤ 0.05; n = 6-10 for each group.
Figure 4 Mucosal polyps in the mucosa of TNFA-/- mice
following NTHi challenge. A. Examples of polyps (arrows) in the
ME mucosa of TNF KO mice at various intervals after NTHi
inoculation. H&E staining. Magnification A-C = 40x, D = 80x. B.
Percentage of ears in which polyps were found in serial sections.
While polyps were common in TNFA-/- MEs, only one polyp was
seen in WT animals. n = 6-10 for each group.
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regulation of their ligand. These included TNFR18,
which regulates T-cell mediated cell death [34,35], and
TNFR19, which can induce apoptosis via JNK signaling
[36]. Others encoded decoy receptors that are anti-
apoptotic, such as TNFR11B, a secreted receptor that
can bind TNF10 [37], and membrane-inserted TNFR22
and TNFR23 [38]. Still others encoded receptors with
functions unrelated to apoptosis, including TNFR5 (B-
cell growth, differentiation and survival [39]) and
TNFR12a (angiogenesis [40]).
It might be hypothesized that apoptosis would be
inhibited early in OM to support mucosal hyperplasia,
and enhanced during OM recovery to remove excess
mucosal cells and leukocytes. Indeed, apoptosis as mea-
sured by TUNEL labeling peaked in WT mice late in
OM. However, apoptosis was also observed early in
OM, and indeed in the normal, uninfected ME. Evaluat-
ing the time courses of gene expression, the various
pro-apoptotic TNF and TNFR genes that are regulated
during acute OM were expressed over its entire time
course, beginning at 3 hours and continuing until
7 days. Thus the genes for Tnfa and its receptors
Tnfr1a and Tnfr1b, Tnf9 and Tnfr9, as well as Tnf1r18
are up-regulated early in OM and decline after day 3,
although Tnfa remained 1.8X up-regulated at day 5.
Tnf10 expression is enhanced throughout OM and that
of Tnfr19 late in OM. Conversely, the various anti-apop-
totic genes are also expressed throughout OM. While
Tnf11 and Tnf14 are expressed early in OM, Tnfr22 and
Tnfr23 are expressed midway through OM, while
Tnfr11b is up-regulated throughout OM. Of course, the
TNFs and their receptors are multifunctional, and no
direct relationship between gene expression and apopto-
sis can be drawn. However, the substrates for both
apoptosis enhancement and inhibition were present
throughout OM.
During development, apoptosis occurs extensively dur-
ing tissue remodeling (e.g. [41]), thus it is not surprising
that pro-apoptotic genes and apoptosis were observed
early in OM as the ME mucosa remodels to adopt a
more respiratory phenotype (e.g. [42]). Also, the
Figure 5 Leukocyte infiltration of the ME during OM. A.
Percentage of the ME lumen occupied by inflammatory cells after
challenge with NTHi in WT (stippled bars) and TNFA-/- (striped bars).
Bars represent means, while lines represent 1 SD. * = p ≤ 0.05; n =
6-10 for each group. B. Micrographs representing the typical
appearance of cellular infiltrates in the two genotypes at 1 and 5
days after NTHi inoculation. Magnification 150× (insert = 400×).
Figure 6 Apoptosis in the ME mucosa during OM. A.
Micrographs illustrating TUNEL-labeled cells in the ME mucosae of
WT versus TNFA-/- mice after inoculation of the ME with NTHi. B.
Percentage of apoptotic cells in the ME mucosa following NTHi
injection. Values are means ± SD; asterisks indicate statistical
significance (p ≤ 0.05); n = 6-10 for each group.
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expression of pro- and anti-apoptotic genes throughout
OM is consistent with current concepts of programmed
cell death, which must be kept under tight regulation to
prevent unwanted loss of cells [e.g. [43,44]]. The peak of
TUNEL labeling observed at 5-10 days after NTHi
inoculation in WT mice presumably reflects an increase
in factors favoring apoptosis and a decrease in anti-
apoptotic factors. To the extent that TNFs and TNFRs
are responsible, pro-apoptotic TNFA and TNF10
(TRAIL) and TNF19 are good candidates to enhance
apoptosis late in OM, while TNFR11B could negatively
regulate apoptosis during OM recovery. The increase in
TUNEL labeling in the ME mucosa coincides with late
changes in the expression of caspase 3 and caspase 4 as
observed in the qPCR data from the WT ME on day 5
after inoculation.
Absence of the TNFA gene during bacterial OM had
profound effects upon the architecture of the ME
mucosa, infiltration of the ME by leukocytes, and apop-
tosis. Even prior to infection, the ME mucosa was
hyperplastic in TNF KO mice, perhaps reflecting
reduced apoptosis in the resting ME resulting in the
accumulation of excess tissue due to altered homeostatic
remodeling. However, while the amount of apoptosis
observed in the TNF KO ME mucosa was lower than
that seen in the WT ME (Figure 6B), this difference was
not statistically significant. Alternatively, hyperplasia in
the TNF KO ME could reflect low-grade infection with
endogenous microorganisms in the absence of this criti-
cal cytokine. We have previously shown that TNFA is
critical to bacterial clearance in the ME, and that
macrophages of TNFA-/- mice display impaired
phagocytosis and intracellular killing of NTHi. In fact,
we cultured bacteria from the MEs of naïve TNFA-/-
mice on chocolate agar (data not shown). However, we
could not identify the organisms and can only speculate
regarding their role.
While the ME mucosa of uninfected TNFA-/- mice
was significantly thicker than that of WTs, NTHi inocu-
lation nevertheless resulted in significant additional
mucosal growth in TNFA-/- animals when compared to
the pre-inoculation state. Hyperplasia of the majority of
the TNFA-/- ME mucosa that occurred after NTHi
inoculation was not significantly different from that seen
in WTs for the first few days, suggesting that TNFA
does not play a role in initial hyperplasia. An exception
was the development of mucosal polyps, which was
observed as early as 1 day after inoculation. However,
recovery of the mucosa to normal thickness was signifi-
cantly delayed by lack of TNFA (Figures 2 and 3). The
reduced apoptosis observed in the ME mucosa of
TNFA-/- mice on day 5, when compared to WTs, seems
likely to contribute to both the persistence of mucosal
thickness and the development of mucosal polyps
(Figure 4). While at later times TNFA-/- animals showed
higher levels of apoptosis, this may reflect the fact that
recovery is complete in the WT ME, while delayed
recovery from hyperplasia continues in TNFA-/- mice.
This finding suggests that impaired recovery from ME
inflammation in TNFA-/- mice, as found by Leichtle et
al. [12] may be the primary reason for persistent ME
mucosal thickness in TNFA-/- mice. The lack of caspase
3 and 4 up-regulation on day 5 in TNFA-/- mice, when
compared to WTs, also seems likely to reflect this
Figure 7 Expression of caspase mRNAs during NTHi-induced OM. In WTs, caspase 3 was expressed only on day 5, while caspase 4 mRNA
was expressed at high levels early in OM, and then again at day 5. While both caspases were expressed at high levels in TNFA-/- MEs prior to
OM, expression declined rapidly and became undetectable soon after inoculation.
Ebmeyer et al. BMC Immunology 2011, 12:12
http://www.biomedcentral.com/1471-2172/12/12
Page 7 of 11
general prolongation of hyperplasia and inflammation.
The observation of increased apoptosis on days 7 and
10 (Figure 6B) further suggests that alternative mechan-
isms for production of mucosal apoptosis must be active
in the MEs of TNFA-/- mice, perhaps mediated by other
pro-apoptotic members of the TNF superfamily such as
TNF10 or, given the results of Rikvin et al. [18], TNF6
(Fas). This apoptosis appears directed at recovery of the
ME mucosa, since the delayed peak in apoptosis in
TNFA-/- mice 7 days post infection correlates with the
time of regression of mucosal polyps (Figure 4).
The prolonged presence of leukocytes in the MEs of
TNFA-/- mice is very unlikely to involve lack of TNFA-
mediated apoptosis, as TNFA does not appear to med-
iate cell death in leukocytes. Neutrophils die by an
intrinsic program of apoptosis, approximately three days
after differentiation, that does not require death ligands
[45], while apoptosis of other classes of leukocytes
involve alternative TNFs such as TNF6 (Fas). Prolonged
inflammation leading to enhanced leukocyte recruitment
or lower levels of leukocyte clearance via vessels seem
more likely, since TNFA has been shown to be involved
in leukocyte trafficking in other systems [46].
Of course, our results are specific to NTHi-induced OM.
However, given the similarity or OM induced by NTHi and
pneumococcus in the mouse [19], and the central role of
TNFA in both inflammation and apoptosis, similar effects
of TNFA deletion might be observed in OM induced by
pneumococcus and perhaps other ME pathogens.
Conclusions
The results of the present study suggest that the TNF
and TNF receptor superfamilies play important roles in
OM, mediating both inflammation and apoptosis. TNFA
appears to be a critical factor for the maintenance of
mucosal architecture in both the normal and infected
ME since excessive accumulation of mucosal tissue is
seen in TNFA-/- MEs both before and after bacterial
inoculation of the ME.
Methods
Animals
6 week old female TNFA-/- mice (B6;129S6-Tnftm1Gkl/J)
were obtained from Jackson Labs (Bar Harbor, ME) and
housed under germ-free conditions. These mice are
homozygous for a targeted mutation in the TNF gene
(Tnfa, Tnfsf2, Tnftm1Gkl) and are therefore TNFA defi-
cient [20,47]. Female B6;129SF2 mice served as WT
controls. These mice provide a close match for the
B6;129 background of the TNFA-/- mice. All animal
experimental procedures followed the appropriate NIH
guidelines. They were reviewed and approved by the
Institutional Animal Use and Care Committee of the
San Diego VA Medical Center, protocol number 07-024.
Bacteria
Haemophilus influenzae strain 3655 (nontypeable, bio-
type II; NTHi) was used at a concentration of 105 - 106/
ml to induce experimental OM. The inocula were pre-
pared as previously described [19,21].
Surgery
Anesthesia was induced by intraperitoneal injection of
0.4 ml per 100 g bodyweight of a rodent cocktail con-
taining 13.3 mg/ml ketamine HCl, 1.3 mg/ml xylazine
and 0.25 mg/ml acepromazine maleat. The ME bullae
were exposed bilaterally through a vertical midline inci-
sion on the neck. A 25 gauge syringe needle was used
to fenestrate the center of the ME bullae. Via this open-
ing, approximately 3-5 μl of NTHi (105/ml) was injected
using an insulin syringe. Excess fluid was absorbed with
a sterile cotton swab, the cervical tissue was replaced
over the fenestrations and the skin incision stapled
closed. The mice were allowed to survive for various
intervals after inoculation.
Gene Expression
Expression of TNF and TNFR family genes was evalu-
ated in WT mice by DNA microarray. Age-matched
C57Bl/6:CB F1 hybrid mice were purchased from Jack-
son Laboratories (Bar Harbor, ME). Twenty mice per
time point were inoculated bilaterally with Haemophilus
influenzae strain 3655 (non-typeable, biotype II, origin-
ally isolated from an OM patient; NTHi), in 5 ml at a
concentration of 105 - 106/ml as described previously
[19,21]. Uninoculated, naive animals (time 0) served as
controls. ME mucosae were harvested and combined at
each of the following intervals: 0 (no treatment), 3 or
6 hours, as well as 1, 2, 3, 5 or 7 days after NTHi inocu-
lation. The tissue was homogenized in TRIzol™ (Invi-
trogen, Carlsbad, CA) and total RNA was extracted.
Total RNA quality was assessed using the RNA 6000
Labchip Kit on the Agilent 2100 Bioanalyzer for the
integrity of 18S and 28S ribosomal RNA. The mRNA
was reverse transcribed using a T7-oligodT primer then
in vitro transcribed using T7 RNA polymerase to gener-
ate biotinylated cRNA probes that were hybridized to
two Affymetrix MU430 2.0 microarrays per sample.
This procedure was then duplicated for each time point
to obtain a second, independent replication, for a total
of 32 arrays for the controls and seven OM time points.
Expression of mRNA encoding caspases 3 and 4 was
evaluated in WT and TNFA-/- mice using qPCR. Mice
were inoculated with NTHi and sacrificed at intervals of
0 or 6 hours, as well as 1, 2, 5 or 10 days. The contents
of at least 6 MEs per time point and genotype were iso-
lated. mRNA was extracted, reverse transcribed, and
1 mg/ml of cDNA was amplified using pre-developed
TaqMan qPCR primers (Applied Biosystems, Foster
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City, CA) for caspase 3 (Mm01195084_m1) and caspase
4 (Mm00432307_m1) in an ABI Prism 7000 Sequence
Detection System (Applied Biosystems). Fold induction
was calculated using the comparative threshold
cycle (Ct) method [48]. Relative expression of each
target gene was normalized to levels of GAPDH
(Mm03302249_g1) and compared to uninfected mucosa.
Histology
The mice were sacrificed by intracardial perfusion with
PBS and 4% paraformaldehyde (PFA) under general
anesthesia, 1, 2, 3, 5, 7 or 10 days after inoculation. The
MEs were isolated and postfixed in 4% PFA overnight.
The ME bullae were decalcified for 14 days in EDTA
and embedded in paraffin. Serial 7 μm sections were
stained with H&E. Digital micrographs were taken from
a standardized region of the ME of each specimen. The
thickness of the epithelial and stromal layers of the
mucosa was measured over approximately 500 μm at a
standard location in the plane of the Eustachian tube
and computer-averaged.
For analysis of the number of inflammatory cells, digi-
tal micrographs were obtained from each specimen in
the plane that displayed the maximum amount of cells
in the ME cavity. The area covered by inflammatory
cells as a percentage of a standard area in the ME cavity
was then calculated using image analysis software.
Apoptosis
For TUNEL labeling, paraffin sections of each ear were
deparaffinized and labeled with the “TACS™ 2 TdT-
DAB In Situ Apoptosis Detection Kit” (Trevigen, Inc.,
Gaithersburg, MD) including positive and negative con-
trols. The percentage of TUNEL positive cells was deter-
mined by enumerating 100 mucosal cells in three
different planes in each specimen. Each ear was also
examined for polyp formation in the ME mucosa in
H&E stained serial sections, as a measure of the accu-
mulation of excess mucosal cells. The percentage of ears
with polyps was calculated. All calculations were per-
formed independently, by two observers, with matching
results.
Statistics
For statistical evaluation of gene array data, raw intensity
data was median normalized and statistical differences in
gene transcript expression levels were evaluated using a
variance-modeled posterior inference approach (VAM-
PIRE) [49]. Specific TNF and TNFR family genes were
assessed at individual time points, after Bonferonni cor-
rection for multiple tests, using Genespring GX 7.3 (Agi-
lent). To quantify differential gene expression, transcript
hybridization levels were expressed as fold change rela-
tive to those obtained for uninfected control (0 hr) MEs.
In the text they have been described as up-regulated if
they were significantly higher than control values, and
down-regulated if they were significantly lower. To docu-
ment statistical significance of morphological and cellular
data, ANOVA was performed on all data using StatView
5.0 statistics calculation software. Differences between
groups were considered significant at p < 0.05.
Additional material
Additional file 1: Table S1. Fold expression data derived from gene
arrays, for the TNF and TNFR family genes presented graphically in Figure
1, including variability (Range) and significance (P-value).
Abbreviations
Ct: comparative threshold cycle; ME: middle ear; KO: knockout; NTHi:
nontypeable Haemophilus influenzae; OM: otitis media; PFA:
paraformaldehyde; TNFA: tumor necrosis factor α; TNFA-/- mice: TNF-deficient
(B6129S6-Tnftm1Gkl/J) mice; TNFR: TNF receptor; TNFsolRI: TNF soluble receptor
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